Influence of clinical and anamnestic factors on the quality of life of patients with coronary heart disease in the post-covid period

INFLUENCE OF CLINICAL AND ANAMNESTIC FACTORS ON THE QUALITY OF LIFE OF PATIENTS WITH CORONARY HEART DISEASE IN THE POST-COVID PERIOD
Abdumalikova F.B., Usmonov Kh.I., Odinayev A.Sh..
Tashkent Medical Academy, Tashkent, Uzbekistan.
Relevance. To date, the clinical and epidemiological specificity of COVID-19, its interaction with comorbid diseases, including cardiovascular disease (CVD), the active study of the postoperative period, the prevention, treatment and rehabilitation of coronavirus infection the search for effective approaches continues to be topical [2]. As a result of the negative impact of COVID-19 on the functional and mental health of patients, it is likely that patients with underlying cardiovascular disease will have a significant impact on quality of life (QOL) in the post-coronavirus infection period. . [1]. The World Health Organization (WHO) defines quality of life as “a comprehensive concept that affects a person’s physical health, their psychological state, their level of independence, social relationships and their dependence on the environment”. [4]. Quality of life is one of the most important aspects of health, especially in patients with cardiovascular disease. According to the WHO, quality of life should be considered as a necessary factor in maintaining good health and treating any disease. Measuring quality of life is the most appropriate and reliable way to assess the impact of disease on a patient's activities, functions and condition. In addition, co-morbidities that affect disease development are another factor in determining a patient’s quality of life. [5] COVID-19 is a serious disease, mainly due to the negative impact of the disease on functional and mental health, mainly in patients with cardiovascular disease, especially coronary heart disease, recovery in the post-COVID-19 period and subsequent quality of life may be affected [1,2].
The purpose of the study. To identify factors that predetermine deterioration in quality of life in patients with coronary artery disease in the post-COVID period.